Lymphoma and Chronic Lymphocytic Leukemia: Updates in Management
This CME course, which took place in April 2022, addressed the rapidly changing landscape in the management and treatment of non-Hodgkin lymphoma, Hodgkin lymphoma, and chronic lymphocytic leukemia. Through presentations by expert thought leaders reviewing the most current data and three panel discussions divided into aggressive lymphomas, indolent lymphomas, and Hodgkin lymphoma/chronic lymphocytic leukemia, participants discussed optimal management and learned the most critical updates in these diseases.
Diffuse Large B-cell Lymphoma: 22 Update
Adam Olszewski, MD, shares updates on Diffuse large B-cell lymphoma.
Updates on Management of Peripheral T-cell Lymphomas
Samuel Ng, MD, PhD, gives updates on the management of Peripheral T-cell lymphomas.
Aggressive Lymphoma Panel Discussion
Austin Kim, MD, Matthew Weinstock, MD, Adam Olszewski, MD, David Fisher, MD, and Samuel Ng, MD, PhD, take audience questions and further discuss aggressive lymphomas in this panel discussion.
Treating Lymphoma in the Older Adult Population
Patrick Johnson, MD, discusses treating lymphoma in the older adult population.
CAR-T Cell Therapy for Lymphoma: Updates and Progress
Caron Jacobson, MD, MMSc, gives updates and shares progress with CAR-T cell therapy for lymphoma.
Elderly Indolent Lymphoma CAR-T Cell Panel Discussion
Austin Kim, MD, Philippe Armand, MD, PhD, and Patrick Johnson, MD, take audience questions and discuss cases of elderly indolent lymphoma CAR-T cell therapy in this panel discussion.
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Inhye Ahn, MD, discusses the background and management of chronic lymphocytic leukemia and small lymphocytic lymphoma.
cHL and CLL SLL Panel Discussion and Conclusion
In this video, the panel takes audience questions and discusses cases of Classical Hodgkin Lymphoma, Chronic Lymphocutic Leukemia, and Small Lymphocytic Lymphoma.
